Mechanisms and mediators of lung injury after acute kidney injury

Nature Reviews Nephrology

Volumn 12, Issue 1, 2016, Pages 48-60

  Faubel, Sarah ^a   Edelstein, Charles L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CASPASE 3; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; APOPTOSIS; ARTIFICIAL VENTILATION; CYTOKINE PRODUCTION; END STAGE RENAL DISEASE; ENDOTHELIUM INJURY; FLUID RESUSCITATION; GENE EXPRESSION; HUMAN; INFLAMMATION; LUNG EDEMA; LUNG INJURY; MEDIATOR; NEPHRECTOMY; NEUTROPHIL; NONCARDIOGENIC LUNG EDEMA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; REVIEW; CHRONIC KIDNEY FAILURE; COMPLICATION;

ACUTE KIDNEY INJURY; HUMANS; KIDNEY FAILURE, CHRONIC; LUNG INJURY;

EID: 84951908237     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2015.158     Document Type: Review

References (146)

1. Uchino, S. et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit. Care Med. 34, 1913-1917 (2006).
2. Star, R. A. Treatment of acute renal failure. Kidney Int. 54, 1817-1831 (1998).
3. Koyner, J. L. et al. The daily burden of acute kidney injury: a survey of, US nephrologists on World Kidney Day. Am. J. Kidney Dis. 64, 394-401 (2014).
4. Xue, J. L. et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J. Am. Soc. Nephrol. 17, 1135-1142 (2006).
5. Uchino, S. et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 33, 1563-1570 (2007).
6. VA/NIH Acute Renal Failure Trial Network, Palevsky, P. M., Zhang, J. H. et al. Intensity of renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359, 7-20 (2008).
7. Chertow, G. M. et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16, 3365-3370 (2005).
8. Liangos, O. et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin. J. Am. Soc. Nephrol. 1, 43-51 (2006).
9. Levy, E. M., Viscoli, C. M., Horwitz, R. I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275, 1489-1494 (1996).
10. Bates, D. W. et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin. Infect. Dis. 32, 686-693 (2001).
11. Chertow, G. M. et al. Independent association between acute renal failure and mortality following cardiac surgery. Am. J. Med. 104, 343-348 (1998).
12. Lassnigg, A. et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J. Am. Soc. Nephrol. 15, 1597-1605 (2004).
13. Parikh, C. R. et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 62, 566-573 (2002).
14. Metnitz, P. G. et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit. Care Med. 30, 2051-2058 (2002).
15. du Cheyron, D. et al. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med. 31, 1693-1699 (2005).
16. Hoste, E., DeCorte, W. D. Clinical Consequences of Acute Kidney Injury. Contrib. Nephrol. 174, 56-64 (2011).
17. Okusa, M., Rosner, M. H. Overview of the management of acute kidney injury (acute renal failure). In: UpToDate. Palevsky, P. M. (ed.), UpToDate, Waltham, MA. (2014).
18. Macedo, E., Bouchard, J., Mehta, R. in Comprehensive Clinical Nephrology. 5th edn Ch. 14. (eds Johnson, R. J., Feehally, J., Floege, J.) 851-853 (Saunders, 2014).
19. KDIGO. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1-138 (2012).
20. Murugan, R., Kellum, J. A. Acute kidney injury: what's the prognosis Nat. Rev. Nephrol. 7, 209-217 (2011).
21. Macedo, E., Mehta, R. L. in Schrier's Diseases of the Kidney. 9th edn Ch. 28. (eds Schrier, R. W., Coffman, T. M., Falk, R. J., Molitoris, B. A., Neilson, E. G.) 795-825 (LWW, 2012).
22. Palevsky, P. Renal replacement therapy (dialysis) in acute kidney injury (acute renal failure) in adults: indications, timing, and dialysis dose. In: UpToDate. Burns, J., Sheridan, A. M. (eds), UpToDate, Waltham, MA. (2013).
23. Teschan, P. E. et al. Prophylactic hemodialysis in the treatment of acute renal failure. Ann. Intern. Med. 53, 992-1016 (1960).
24. Frank, H. A., Seligman, A. M., Fine, J. Further experiences with peritoneal irrigation for acute renal failure: including a description of modifications in method. Ann. Surg. 128, 561-608 (1948).
25. Wacker, W., Merrill, J. P. Uremic pericarditis in acute and chronic renal failure. JAMA 156, 764-765 (1954).
26. Cahalane, S. F. et al. Acquired thrombocytopathy: observations on the coagulation defect in uremia. Am. J. Clin. Pathol. 30, 507-513 (1958).
27. Bagshaw, S. M. et al. Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit. Care. 12, 169 (2008).
28. Bouchard, J. et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 76, 422-427 (2009).
29. Vaara, S. T. et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit. Care 16, R197 (2012).
30. Mehta, R. L. et al. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med. 37, 241-248 (2011).
31. Ronco, C., House, A. A., Haapio, M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 34, 957-962 (2008).
32. Waikar, S. S., Liu, K. D., Chertow, G. M. The incidence and prognostic significance of acute kidney injury. Curr. Opin. Nephrol. Hypertens. 16, 227-236 (2007).
33. Himmelfarb, J. et al. Impaired monocyte cytokine production in critically ill patients with acute renal failure. Kidney Int. 66, 2354-2360 (2004).
34. Hassoun, H. T. et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am. J. Physiol. Renal Physiol. 293, F30-F40 (2007).
35. Kramer, A. A. et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int. 55, 2362-2367 (1999).
36. Kelly, K. J. Distant effects of experimental renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 14, 1549-1558 (2003).
37. Kim, M. et al. Isoflurane activates intestinal sphingosine kinase to protect against bilateral nephrectomy-induced liver and intestine dysfunction. Am. J. Physiol. Renal Physiol. 300, F167-F176 (2011).
38. Yildirim, A. et al. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Ann. Clin. Lab. Sci. 33, 459-464 (2003).
39. Liu, M. et al. Acute kidney injury leads to inflammation and functional changes in the brain. J. Am. Soc. Nephrol. 19, 1360-1370 (2008).
40. Park, S. W. et al. Paneth cell-mediated multiorgan dysfunction after acute kidney injury. J. Immunol. 189, 5421-5433 (2012).
41. Scheel, P. J., Liu, M., Rabb, H. Uremic lung: new insights into a forgotten condition. Kidney Int. 74, 849-851 (2008).
42. Kelly, K. J. Acute renal failure: much more than a kidney disease. Semin. Nephrol. 26, 105-113 (2006).
43. Awad, A. S., Okusa, M. D. Distant organ injury following acute kidney injury. Am. J. Physiol. Renal Physiol. 293, F28-29 (2007).
44. Faubel, S. Acute kidney injury and multiple organ dysfunction syndrome. Minerva Urol. Nefrol. 61, 171-188 (2009).
45. Faubel, S. Pulmonary complications after acute kidney injury. Adv. Chronic Kidney Dis. 15, 284-296 (2008).
46. Imai, Y. et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 289, 2104-2112 (2003).
47. Liu, K. D. et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit. Care 13, R104 (2009).
48. Bhargava, R. et al. Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-antibodies. PLoS ONE 8, e79037 (2013).
49. Chertow, G. M. et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch. Intern. Med. 155,1505-1511 (1995).
50. Mehta, R. L. et al. Refining predictive models in critically ill patients with acute renal failure. J. Am. Soc. Nephrol. 13, 1350-1357 (2002).
51. Neveu, H. et al. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol. Dial. Transplant. 11, 293-299 (1996).
52. Uchino, S. et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813-818 (2005).
53. Lins, R. L. et al. Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study. Nephrol. Dial. Transplant. 19, 2282-2288 (2004).
54. Chertow, G. M. et al. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J. Am. Soc. Nephrol. 9, 692-698 (1998).
55. Paganini, E. P., Halstenberg, W. K., Goormastic, M. Risk modeling in acute renal failure requiring dialysis: the introduction of a new model. Clin. Nephrol. 46, 206-211 (1996).
56. Liano, F. et al. Prognosis of acute tubular necrosis: an extended prospectively contrasted study. Nephron 63, 21-31 (1993).
57. Demirjian, S. et al. Model to predict mortality in critically ill adults with acute kidney injury. Clin. J. Am. Soc. Nephrol. 6, 2114-2120 (2011).
58. Pike, F. et al. Biomarker enhanced risk prediction for adverse outcomes in critically ill patients receiving RRT. Clin. J. Am. Soc. Nephrol. 10, 1332-1339 (2015).
59. [No authors listed] Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med. 342, 1301-1308 (2000).
60. Vieira, J. M. et al. Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients. Crit. Care Med. 35, 184-191 (2007).
61. Grassi, V. et al. Uremic lung. Contrib. Nephrol. 106, 36-42 (1994).
62. Alwall, N., Lunderquist, A., & Olsson, O. Studies on electrolyte-fluid retention. I. Uremic lung, fluid lung On pathogenesis and therapy; a preliminary report. Acta Med. Scand. 146, 157-163 (1953).
63. Kwiatkowski, D. M. et al. Improved outcomes with peritoneal dialysis catheter placement after cardiopulmonary bypass in infants. J. Thorac. Cardiovasc. Surg. 149, 230-236 (2015).
64. Payen, D. et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit. Care 12, R74 (2008).
65. Bouchard, J. et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 76, 422-427 (2009).
66. Matthay, M. A., Ware, L. B., Zimmerman, G. A. The acute respiratory distress syndrome. J. Clin. Invest. 122, 2731-2740 (2012).
67. Rackow, E. C., Fein, I. A., Sprung, C., Grodman, R. S. Uremic pulmonary edema. Am. J. Med. 64, 1084-1088 (1978).
68. Gibson, D. G. Haemodynamic factors in the development of acute pulmonary oedema in renal failure. Lancet 2, 1217-1220 (1966).
69. Matthay, M. A., Zimmerman, G. A. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am. J. Respir. Cell. Mol. Biol. 33, 319-327 (2005).
70. Zettergren, L. Uremic lung; report of four cases reaching autopsy. Acta Soc. Med. Ups. 60, 161-171 (1955).
71. Hopps, H. C., Wissler, R. W. Uremic pneumonitis. Am. J. Pathol. 31, 261-273 (1955).
72. Roubier, C., Plauchau, M. Sur certains aspects radiographiques de l'ooedème pulmonaire chez les cardiorénaux azotémiques [French]. Arch. Méd-chir de l'app. Respire. 9, 189 (1934).
73. Bass, H. E. et al. Pulmonary changes in uremia. JAMA 148, 724-726 (1952).
74. Bleyl, U., Sander, E., Schindler, T. The pathology and biology of uremic pneumonitis. Intensive Care Med. 7, 193-202 (1981).
75. Simmons, E. M. et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 65, 1357-1365 (2004).
76. Chawla, L. S. et al. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin. J. Am. Soc. Nephrol. 2, 22-30 (2007).
77. Zhang, W. R. et al. Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery. J. Am. Soc. Nephrol. http://dx.doi.org/ASN.2014080764.
78. Murugan, R. et al. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol. Dial. Transplant. 29, 1854-1864 (2014).
79. Liangos, O. et al. Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study. Nephron Clin. Pract. 113, c148-c154 (2009).
80. Bless, N. M. et al. Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am. J. Physiol. 276, L57-63 (1999).
81. Colletti, L. M. et al. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 10, 182-191 (1998).
82. Colletti, L. M. et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J. Clin. Invest. 95, 134-141 (1995).
83. Seekamp, A. et al. Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. Am. J. Pathol. 143, 464-472 (1993).
84. Yoshidome, H., Kato, A., Edwards, M. J., Lentsch, A. B. Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion. Am. J. Physiol. 277, L919-923 (1999).
85. Yoshidome, H. et al. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. J. Surg. Res. 81, 33-37 (1999).
86. Depass, S. W. et al. Pulmonary congestion and edema in uremia. JAMA 162, 5-9 (1956).
87. Kuebler, W. M. et al. Pressure is proinflammatory in lung venular capillaries. J. Clin. Invest. 104, 495-502 (1999).
88. Wiedemann, H. P. et al. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354, 2564-2575 (2006).
89. Hoke, T. S. et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J. Am. Soc. Nephrol. 18, 155-164 (2007).
90. Clermont, G. et al. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int. 62, 986-996 (2002).
91. Knaus, W. A. et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100, 1619-1636 (1991).
92. Ostermann, M., Chang, R. Renal failure in the intensive care unit: acute kidney injury compared to end-stage renal failure. Crit. Care 12, 432 (2008).
93. Rocha, E. et al. Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study. Nephrol. Dial. Transplant. 24, 1925-1930 (2009).
94. Hussain, S. et al. Outcome among patients with acute renal failure needing continuous renal replacement therapy: a single center study. Hemodial. Int. 13, 205-214 (2009).
95. Walcher, A. et al. In critically ill patients requiring CRRT, AKI is associated with increased respiratory failure and death versus ESRD. Ren. Fail. 33, 935-942 (2011).
96. Kramer, H. J. et al. Increasing body mass index and obesity in the incident ESRD population. J. Am. Soc. Nephrol. 17, 1453-1459 (2006).
97. Bellingan, G. J. The pulmonary physician in critical care, 6: The pathogenesis of ALI/ARDS. Thorax 57, 540-546 (2002).
98. Chonchol, M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin. Dial. 19, 291-296 (2006).
99. Tsalik, E. L. et al. Renal systems biology of patients with systemic inflammatory response syndrome. Kidney Int. http://dx.doi.org/10.1038/ki.2015.150.
100. Matute-Bello, G. et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44, 725-738 (2011).
101. Tremblay, L. et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J. Clin. Invest. 99, 944-952 (1997).
102. Hu, G. et al. Intercellular adhesion molecule-1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability. Circ. Res. 102, e120-131 (2008).
103. Zarbock, A. et al. Acute uremia but not renal inflammation attenuates aseptic acute lung injury: a critical role for uremic neutrophils. J. Am. Soc. Nephrol. 17, 3124-3131 (2006).
104. Deng, J., Hu, X., Yuen, P. S., Star, R. A. Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am. J. Respir. Crit. Care Med. 169, 749-756 (2004).
105. Klein, C. L. et al. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int. 74, 901-909 (2008).
106. Ahuja, N. et al. Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice. Am. J. Physiol. Renal Physiol. 303, F864-F872 (2012).
107. Gu, J. et al. Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice. Acta. Anaesthesiol. Scand. 55, 1272-1278 (2011).
108. Doi, K. et al. The high-mobility group protein B1-Toll-like receptor 4 pathway contributes to the acute lung injury induced by bilateral nephrectomy. Kidney Int. 86, 316-326 (2014).
109. White, L. E. et al. TNFR1-dependent pulmonary apoptosis during ischemic acute kidney injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L449-L459 (2012).
110. Awad, A. S. et al. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int. 75, 689-698 (2009).
111. Lee, W. L., Downey, G. P. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care. 7, 1-7 (2001).
112. Feltes, C. M. et al. Pulmonary endothelial cell activation during experimental acute kidney injury. Shock 36, 170-176 (2011).
113. Klein, C. L. et al. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int. (2008).
114. Andres-Hernando, A. et al. Splenectomy exacerbates lung injury after ischemic acute kidney injury in mice. Am. J. Physiol. Renal Physiol. 301, F907-F916 (2011).
115. Grigoryev, D. N. et al. The local and systemic inflammatory transcriptome after acute kidney injury. J. Am. Soc. Nephrol. 19, 547-558 (2008).
116. Kim do, J. et al. Comparison of experimental lung injury from acute renal failure with injury due to sepsis. Respiration 73, 815-824 (2006).
117. Ma, T., Liu, Z. Functions of aquaporin 1 and alpha-epithelial Na+ channel in rat acute lung injury induced by acute ischemic kidney injury. Int. Urol. Nephrol. 45, 1187-1196 (2013).
118. Hassoun, H. T. et al. Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis. Am. J. Physiol. Renal Physiol. 297, F125-F137 (2009).
119. Heidland, A. et al. Uremic pneumonitis. Evidence for participation of proteolytic enzymes. Contrib. Nephrol. 41, 352-366 (1984).
120. Peterson, B. T., Brooks, J. A., Hyde, R. W. Lung fluid balance during acute renal failure in sheep. J. Appl. Physiol. 60, 1333-1340 (1986).
121. Rabb, H. et al. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int. 63, 600-606 (2003).
122. Lie, M. L. et al. Lung T lymphocyte trafficking and activation during ischemic acute kidney injury. J. Immunol. 189, 2843-2851 (2012).
123. Altmann, C. et al. Macrophages mediate lung inflammation in a mouse model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 302, F421-F432 (2012).
124. Liu, K. D. et al. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit. Care Med. 35, 2755-2761 (2007).
125. Meduri, G. U. et al. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108, 1303-1314 (1995).
126. Parsons, P. E. et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med. 33, 1-6 (2005).
127. Bhargava, R. et al. Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice. PLoS ONE 8, e61405 (2013).
128. Kamimura, D., Ishihara, K., Hirano, T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149, 1-38 (2003).
129. Calabrese, L. H., Rose-John, S. IL-6 biology: implications for clinical targeting in rheumatic disease. Nat. Rev. Rheumatol. 10, 720-727 (2014).
130. Meng, Z. H. et al. Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am. J. Physiol. Cell Physiol. 280, C343-C351 (2001).
131. Wolters, P. J. et al. Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J. Immunol. 182, 8056-8062 (2009).
132. Xing, Z. et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311-320 (1998).
133. Andres-Hernando, A. et al. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy. Nephrol. Dial. Transplant. 27, 4339-4347 (2012).
134. Kielar, M. L. et al. Maladaptive role of IL-6 in ischemic acute renal failure. J. Am. Soc. Nephrol. 16, 3315-3325 (2005).
135. Zhang, Y. et al. Ischemia-reperfusion induces G.-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro. Am. J. Physiol. Renal Physiol. 286, F1193-F1201 (2004).
136. Faubel, S. et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 322, 8-15 (2007).
137. Dennen, P. et al. Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. Crit. Care 14, R181 (2010).
138. Meduri, G. U. et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107, 1062-1073 (1995).
139. Belperio, J. A. et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110, 1703-1716 (2002).
140. Puneet, P., Moochhala, S., Bhatia, M. Chemokines in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L3-15 (2005).
141. White, L. E. et al. Lung endothelial cell apoptosis during ischemic acute kidney injury. Shock 38, 320-327 (2012).
142. Andres-Hernando, A. et al. Prolonged acute kidney injury exacerbates lung inflammation at 7 days post-acute kidney injury. Physiol. Rep. 2, e12084 (2014).
143. Palevsky, P. M. et al. KDOQI US commentary on the KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis. 61, 649-672 (2013).
144. Coca, S. G. et al. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 78, 926-933 (2010).
145. Rivers, E. et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345, 1368-1377 (2001).
146. Faubel, S. et al. Ongoing clinical trials in AKI. Clin. J. Am. Soc. Nephrol. 7, 861-873 (2012).